Acrylamide and glycidamide hemoglobin adducts and epithelial ovarian cancer: a nested case-control study in non-smoking postmenopausal women from the EPIC cohort.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, no. 1 (2016): 127.0-134.0

Cited by: 18|Views21
WOS

Abstract:

Background: Acrylamide was classified as "probably carcinogenic to humans (group 2A)" by the International Agency for Research on Cancer. Epithelial ovarian cancer (EOC) is the fourth cause of cancer mortality in women. Five epidemiological studies have evaluated the association between EOC risk and dietary acrylamide intake assessed usin...More

Code:

Data:

ZH
Get fulltext within 24h
Bibtex
Your rating :
0

 

Tags
Comments